Medicare prescription drug cost, prescriptions and prescribers, 2024
Medicare cost, 2024
$2.8M
+0.2% from 2023
Prescriptions
62
$44,935.88 per claim
Patients
-
5 prescribers
Total spending, 2024
$2.8M
- per patient
Medicare prescription drug plans paid $2.8M for Elelyso in 2024, for 62 prescriptions and refills to - patients (up 0.2% from 2023). The average cost per claim was $44,935.88.
California had the highest Medicare cost for Elelyso in 2024: $748K for 13 claims, followed by Florida ($521K).
Julie Huynh, hematology-oncology in Westlake Village, CA, had the highest Medicare cost for Elelyso in 2024: 13 claims costing $748K.
Elelyso is made by Pfizer Inc. (PFE), listed in the Medicare spending data as Pfizer US Pharm.
All plans and makers
Where the prescribers practice, 2024
By Medicare drug cost
| Prescriber | Type | Claims | Patients | Cost |
|---|---|---|---|---|
| Julie Huynh Westlake Village, CA | Hematology-Oncology | 13 | Under 11 | $748K |
| Alexander Brown Pensacola, FL | Hematology-Oncology | 13 | Under 11 | $521K |
| Anna S Griffith |
| Year | Prescribers | Claims | Patients | Cost |
|---|---|---|---|---|
| 2022 | 9 | 88 | - | $3.7M |
| 2023 | 9 | 64 | - | $2.8M |
| 2024 | 5 | 62 | - | $2.8M |
Spending by manufacturer as listed in the spending data
Amount reimbursed by state Medicaid programs, all states
More drugs: top Medicare drugs by cost and the Prescriptions tab.
Official US government data on Medicare prescription drug plans (Part D) and Medicaid drug use. Cost and spending are before the rebates drug makers pay. Prescribers with fewer than 11 claims of the drug are not published.
| Hematology-Oncology |
| 14 |
| Under 11 |
| $505K |
| Jaime E Vengoechea Barrios Atlanta, GA | Medical Genetics and Genomics | 13 | Under 11 | $469K |
| Manufacturer | Claims | Spending |
|---|---|---|
| Pfizer US Pharm PFE | 62 | $2.8M |